首页 | 官方网站   微博 | 高级检索  
     

儿童运动及智能障碍者四氢生物蝶呤代谢病筛查及基因研究
引用本文:叶军,刘晓青,邱文娟,韩连书,周建德,张雅芬,顾学范. 儿童运动及智能障碍者四氢生物蝶呤代谢病筛查及基因研究[J]. 中华医学遗传学杂志, 2007, 24(2): 210-212
作者姓名:叶军  刘晓青  邱文娟  韩连书  周建德  张雅芬  顾学范
作者单位:200092,上海交通大学医学院附属新华医院,上海市儿科医学研究所
基金项目:上海市高等学校科学技术发展基金(03BK12);上海市重点学科建设项目(T0204)
摘    要:目的探讨四氢生物蝶呤(tetrahydrobiopterin,BH4)代谢中各酶缺乏在儿童运动及智能发育障碍者中发生率及基因突变。方法对100例运动及智能障碍患者进行苯丙氨酸(phenylalanine,Phe)及BH4负荷试验、尿蝶呤谱分析、红细胞二氢蝶啶还原酶测定,并对部分患者进行多巴治疗性诊断;对诊断为多巴反应性肌张力障碍(dopa-responsive dystonia,DRD)及6-丙酮酰四氢蝶呤合成酶(6-pyruvoyl tetrahydropterin synthase,PTS)缺乏者做基因突变检测。结果100例中70例基础血Phe浓度正常,6例(6%)诊断为DRD;30例有高苯丙氨酸血症[Phe(1022±290)μmol/L],8例(8%)诊断为VIS缺乏症,22例(22%)诊断为苯丙氨酸羟化酶缺乏症。发现2例DRD患者其三磷酸鸟苷环化酶基因(GTP cyclohydrolase 1 gene,GCHI)突变为IVS5+3insT,8例FIS缺乏症患者存在PTS基因7种突变类型,其中259C→T,286G→A,155A→G最常见,占75%。结论一些肌张力障碍或智能障碍者是由于BH4代谢障碍所致,有必要做筛查诊断以明确诊断。

关 键 词:四氢生物蝶呤 6-丙酮酰四氢蝶呤合成酶 苯丙氨酸羟化酶 多巴反应性肌张力障碍 智能障碍
修稿时间:2006-08-23

Screening for tetrahydrobiopterin metabolic disorders and related gene analysis among the patients with motor disturbance and mental retardation
YE Jun,LIU Xiao-qing,QIU Wen-juan,HAN Lian-shu,ZHOU Jian-de,ZHANG Ya-fen,GU Xue-fan. Screening for tetrahydrobiopterin metabolic disorders and related gene analysis among the patients with motor disturbance and mental retardation[J]. Chinese journal of medical genetics, 2007, 24(2): 210-212
Authors:YE Jun  LIU Xiao-qing  QIU Wen-juan  HAN Lian-shu  ZHOU Jian-de  ZHANG Ya-fen  GU Xue-fan
Affiliation:Affiliated Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai Institute for Pediatric Research, Shanghai, 200092 P. R. China
Abstract:OBJECTIVE: To study the incidence of various enzyme deficiency in tetrahydrobiopterin (BH4) metabolism and the related gene mutation among the patients with motor disturbance and mental retardation. METHODS: One hundred patients with unknown motor disturbance and mental retardation were referred to this study. All patients were performed by phenylalanine (Phe) and BH4 loading test, urinary pterin analysis and dihydropteridine reductase (DHPR) activity. Some patients received the dopa treatment for diagnosis of dopa-responsive dystonia (DRD). The analysis of GTP cyclohydrolase 1 gene (GCH1) mutation for DRD patients and the analysis of 6-pyruvoyl tetrahydropterin synthase (PTS) gene mutations for PTS deficient patients were done under the consent from their parents. RESULTS: Seventy of 100 patients had normal basic blood Phe levels, six (6%) patients were diagnosed as DRD. Thirty patients had hyperphenylalaninemia (HPA), eight (8%) were diagnosed as PTS deficiency and 22(22%) were diagnosed as phenylalanine hydroxylase (PAH) deficiency. All patients had normal DHPR activity. The mutation IVS5+3insT of GCH1 was found in 2 patients with DRD. Seven kinds of PTS mutations were found in 8 patients with PTS deficiency, and 75% of the mutations were 259C-->T,286G-->A and 155A-->G. CONCLUSION: Some patients with unknown motor disturbance and mental retardation may suffer from BH4 metabolism related diseases. Theses patients are necessary to be screened for such kind of diseases in order to confirm the diagnosis.
Keywords:tetmhydrobiopterin   6-pyruvoyl tetrahydropterin synthase   phenylalanine hydroxylase   doparesponsive dystonia   mental retardation
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号